144 related articles for article (PubMed ID: 11962346)
1. Molecular detection of gene mutations and methylation abnormalities: applications in solid tumor diagnosis.
Kraus A; Schuermann M
Expert Rev Mol Diagn; 2002 Mar; 2(2):97-108. PubMed ID: 11962346
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnostic applications of DNA methylation technology.
Cottrell SE
Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
4. Circulating methylated DNA.
Herman JG
Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
[TBL] [Abstract][Full Text] [Related]
5. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
[TBL] [Abstract][Full Text] [Related]
6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
8. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
11. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
Li J; Makrigiorgos GM
Biochem Soc Trans; 2009 Apr; 37(Pt 2):427-32. PubMed ID: 19290875
[TBL] [Abstract][Full Text] [Related]
12. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
Henrique R; Jerónimo C
Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
[TBL] [Abstract][Full Text] [Related]
16. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation analysis: a powerful new tool for lung cancer diagnosis.
Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
Oncogene; 2002 Aug; 21(35):5450-61. PubMed ID: 12154407
[TBL] [Abstract][Full Text] [Related]
18. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
19. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
Seiden M; Sklar JL
Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
[No Abstract] [Full Text] [Related]
20. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
